Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: Follow-up of a randomized clinical trial

Robine Donken, Simon R.M. Dobson, Kim D. Marty, Darrel Cook, Chantal Sauvageau, Vladimir Gilca, Marc Dionne, Shelly McNeil, Mel Krajden, Deborah Money, James Kellner, David W. Scheifele, Tobias Kollmann, Julie A. Bettinger, Shuzhen Liu, Joel Singer, Monika Naus, Manish Sadarangani, Gina S. Ogilvie